Olink to present at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Olink Holding AB (Nasdaq: OLK) will participate in the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 9:00 am ET. CEO Jon Heimer is scheduled to present, with a live and archived webcast available on the company’s website. Olink focuses on accelerating proteomics to enable new scientific discoveries and improve patient outcomes. Founded in 2016, Olink is established in Europe, North America, and Asia, providing products and services for biopharmaceutical companies and academic institutions.

News Market Reaction – OLK

-11.06%

-11.06% Session move

In the trading session that priced this news, OLK declined 11.06%, reflecting a significant negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UPPSALA, Sweden, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced it will be virtually participating in the 40th Annual J.P. Morgan Healthcare Conference.

Jon Heimer, CEO, is scheduled to present on Wednesday, January 12th, 2022, at 9:00 am ET.

A live and archived webcast of the event will be available on the “Investors” section of the Company’s website at https://investors.olink.com/investor-relations.

About Olink
Olink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The company was founded in 2016 and is well established across Europe, North America and Asia. Olink is headquartered in Uppsala, Sweden.

For more information please contact:

IR Contact
Jan Medina, CFA
VP Investor Relations & Capital Markets
Mobile: +1 617 802 4157
jan.medina@olink.com  

Media Contact
Andrea Prander
Corporate Communications Manager
Mobile: + 46 768 775 275
andrea.prander@olink.com

FAQ

When is Olink presenting at the J.P. Morgan Healthcare Conference?

Olink is scheduled to present on January 12, 2022, at 9:00 am ET.

How can I watch Olink's presentation at the conference?

A live and archived webcast of Olink's presentation will be available on the 'Investors' section of their website.

What does Olink Holding AB focus on?

Olink focuses on accelerating proteomics to enable scientific discoveries and improve patient outcomes.

When was Olink founded?

Olink was founded in 2016.

Where is Olink headquartered?

Olink is headquartered in Uppsala, Sweden.